High pre-treatment neutrophil-to-lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent/metastatic cervical cancer treated with immune checkpoint inhibitors

• Main Authors: Corinne A. Calo (Author), David A. Barrington (Author), Morgan Brown (Author), Lynette Gonzalez (Author), Jae Baek (Author), Allison Huffman (Author), Jason Benedict (Author), Floor Backes (Author), Laura Chambers (Author), David Cohn (Author), Larry Copeland (Author), Casey Cosgrove (Author), Christa Nagel (Author), David O'Malley (Author), Kristin Bixel (Author)
• Format: Book
• Published: Elsevier, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: To evaluate the association between pre-treatment neutrophil-to-lymphocyte ratio (NLR) and survival outcomes among patients with recurrent/metastatic cervical cancer treated with PD-1/PD-L1 inhibitors. Methods: A retrospective analysis of patients with recurrent/metastatic cervical cancer...